Skip to content

Comparative clinical study of Vish Taila and Marichyadi Taila in Psoriasis.

A Comparative Pharmaceutico-clinical study of Vish Taila and Marichyadi Taila in ‘Kitibh’ w.s.r. to Psoriasis.

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/02/049548
Enrollment
66
Registered
2023-02-08
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L409- Psoriasis, unspecified

Interventions

None listed

Sponsors

Dr Rajeshwari Nandkishor Ahirrao
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients suffering from classical symptoms of Kitibh- Rukshata, Kinakhara sparsha, Kandu, Parushata, Asita varna. 2. Patients of plaque psoriasis. 3. Patients having any number of lesions.

Exclusion criteria

Exclusion criteria: 1. Age below 16 years and above 70 years. 2. Patients having systemic disorders like Diabetes, cardiac, renal, endocrine disorders. 3. Patients having particular allergy. 4. k/c/o HIV, hepatitis, cancer, burn and post-burn. 5. Patients of psoriatic arthropathy, erythroderma and forms of psoriasis other than plaque psoriasis.

Design outcomes

Primary

MeasureTime frame
To evaluate and compare the efficacy of Vish Taila and Marichyadi Taila in Kitibh based on reduction in PASI score,Auspitz sign, candle grease sign,Itching and dryness.Timepoint: Follow up will be taken on Day-30, 60 and 90

Secondary

MeasureTime frame
Not applicableTimepoint: Not applicable

Countries

India

Contacts

Public ContactDr Rajeshwari Nandkishor Ahirrao

Shri Ayurved Mahavidyalaya, Nagpur

vinodramteke1970@gmail.com9423414191

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026